Product Information

QUETIAPINE 150 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.2219 per EA under NDC 16571080901. Its NADAC has been published 166 times since Jun 21, 2023.

FDA first approved this application on Mar 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUETIAPINE 150 MG TABLET

Quetiapine Fumarate
$1.2219per EA

Strength

150 mg/1

NDC

16571080901

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

QUETIAPINE FUMARATE

Approval Type

Generic (ANDA)

FDA Application

ANDA091388

FDA Approved

3/27/2012

TE Code

AB

On Market Since

3/27/2012

Pharmacological Classes

Price Statistics

The NADAC for QUETIAPINE 150 MG TABLET has been published 166 times since Jun 21, 2023, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2219 per EA
All-time high$1.2809 (Mar 11, 2026)
All-time low$0.9540 (Nov 20, 2024)
52-week high$1.2809
52-week low$1.1998
Median price$1.1805
Average price$1.1744
Largest weekly change-14.6% (Nov 20, 2024)
Weeks tracked166
Tracking sinceJun 21, 2023

Price History

1W

-0.2%

1M

-0.2%

3M

-2.1%

6M

-4.6%

1Y

+0.1%

3Y

+4.7%

5Y

N/A

All

+4.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Quetiapine Fumarate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of QUETIAPINE 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE 150 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $1.2219 per EA (NDC 16571080901), effective Aug 19, 2026.

How has the price of QUETIAPINE 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for QUETIAPINE 150 MG TABLET has risen 4.7%. It has been tracked across 166 weekly CMS publications since Jun 21, 2023.

What are the highest and lowest recorded NADAC prices for QUETIAPINE 150 MG TABLET?

Since Jun 21, 2023, the NADAC for QUETIAPINE 150 MG TABLET has ranged from a low of $0.9540 (Nov 20, 2024) to a high of $1.2809 (Mar 11, 2026), with a median of $1.1805 per EA.

Are there cheaper alternatives to QUETIAPINE 150 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of QUETIAPINE 150 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures QUETIAPINE 150 MG TABLET?

QUETIAPINE 150 MG TABLET (NDC 16571080901) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.